Management of Brain Metastases in Tyrosine Kinase Inhibitor-Naive Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer: Radiotherapy or TKI?

FU  Xiao-long; TAN  Pei-xin

doi:10.12019/j.issn.1671-5144.2018.01.013

FU Xiao-long, TAN Pei-xin. Management of Brain Metastases in Tyrosine Kinase Inhibitor-Naive Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer: Radiotherapy or TKI?[J]. Journal of Evidence-Based Medicine, 2018, 18(1): 40-42. DOI: 10.12019/j.issn.1671-5144.2018.01.013

Citation:

FU Xiao-long, TAN Pei-xin. Management of Brain Metastases in Tyrosine Kinase Inhibitor-Naive Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer: Radiotherapy or TKI?[J]. Journal of Evidence-Based Medicine, 2018, 18(1): 40-42. DOI: 10.12019/j.issn.1671-5144.2018.01.013

Citation:

FU Xiao-long, TAN Pei-xin. Management of Brain Metastases in Tyrosine Kinase Inhibitor-Naive Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer: Radiotherapy or TKI?[J]. Journal of Evidence-Based Medicine, 2018, 18(1): 40-42. DOI: 10.12019/j.issn.1671-5144.2018.01.013

Management of Brain Metastases in Tyrosine Kinase Inhibitor-Naive Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer: Radiotherapy or TKI?

Graphical Abstract

Graphical Abstract

Abstract

FullText(HTML)

References (0)

Management of Brain Metastases in Tyrosine Kinase Inhibitor-Naive Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer: Radiotherapy or TKI?

Graphical Abstract

Catalog

Export File

Citation

Format

Content